Brachytherapy and survival in small cell cancer of the cervix and uterus.

ABSTRACT:

Purpose

Small cell cancer involving the cervix and uterus is considered the same rare disease, but management is controversial and disparate. Patterns of care and outcomes in the United States are unclear.

Methods and materials

Clinical data from patients with small cell cancer of the cervix and uterus were abstracted from the National Cancer Database from 2004 to 2014. Patients with missing clinical stage, incomplete followup, or receiving treatment >90 days from diagnosis were excluded.

Results

There were 621 cervical and 95 uterine patients with cancer treated from 2004 to 2014. Compared to patients with a cervix primary site, patients with a uterine primary site were older (median age 64 years vs. 47 years), more likely to present with distant metastatic disease (

SUBMITTER: Lin AJ 

PROVIDER: S-EPMC7008011 | biostudies-literature | 2019 Mar - Apr

REPOSITORIES: biostudies-literature